Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis (Q34993216)

5 August 2017

1 reference

title

Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis (English)

1 reference

5 August 2017

Rachel R Caspi

1

0 references

publication date

1 March 2002

1 reference

International Reviews of Immunology

5 August 2017

1 reference

5 August 2017

21

1 reference

5 August 2017

2-3

1 reference

5 August 2017

197-208

1 reference

Experimental autoimmune uveitides: multiple antigens, diverse diseases

5 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Autoimmunity in the eye and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

21 January 2018

IL-12 in autoimmunity.

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

The Th1/Th2 balance in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

IL-10 has a protective role in experimental autoimmune uveoretinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Central tolerance mechanisms in control of susceptibility to autoimmune uveitic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Non-Th2 regulatory T-cell control of Th1 autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

When engineered to produce latent TGF-beta1, antigen specific T cells down regulate Th1 cell-mediated autoimmune and Th2 cell-mediated allergic inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180212063

21 January 2018

Identifiers

DOI

10.1080/08830180212063

1 reference

5 August 2017

1 reference

PubMed ID

12424843